Supporting information on the proposal to amend access criteria for type 2 diabetes medicines
On this page, you will find the information relating to Pharmac and our Board's consideration of the this proposal.
Board papers
Clinical Advice
Included here are the official records of clinical advice we received and the documents sent to the committee and advisory group to seek their advice.
December 2025 Record of the Obesity Treatment Advisory Group [PDF, 332 KB]
June 2025 Record of the Diabetes Advisory Committee meeting [PDF, 194 KB]
June 2025 Slides for discussion with the Diabetes Advisory Committee meeting [PDF, 1.8 MB]
Economic information
Factors for consideration
We use summaries like these as part of the prioritisation process. This is a summary prepared by our health economists using the information from the Technology Assessment Report.
Technology Assessment Report (TAR)
TAR reports are developed by our health economists so we can understand all the costs and benefits of a treatment, including the financial and health costs.
Budget impact analysis
These are the spreadsheets we use to try to understand how many people may be affected by our decision and what things may cost.
December 2025 Budget impact summary (base case) [XLSX, 3.5 MB]